Skip to content

ClearPoint Neuro CLPT Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

Abbott logo
AbbottABT
Boston Scientific logo
Boston ScientificBSX
IAR
Integra LifeSciencesIART
Neuropace, Inc. logo
Neuropace, Inc.NPCE
Penumbra logo
PenumbraPEN
Merit Medical Systems logo
Merit Medical SystemsMMSI

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Gross profit$7.8M+51.1%
Operating income-$8.5M-37.6%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Cash & equivalents$36.5M+195%
Total debt$63.6M+1,750%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Market cap$538.61M+69.2%
Enterprise value$565.68M+82.9%
P/S13.3×+3.4×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
Net margin-71.6%+8.8pp
FCF margin-65.7%+269pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Reported directly by ClearPoint Neuro in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ClearPoint Neuro's operating lease right-of-use assets in other assets?
ClearPoint Neuro (CLPT) reported operating lease right-of-use assets in other assets of $13.09M in Q1 2026.
How has ClearPoint Neuro's operating lease right-of-use assets in other assets changed year-over-year?
ClearPoint Neuro's operating lease right-of-use assets in other assets increased by 342.2% year-over-year, from $2.96M to $13.09M.
What is the long-term trend for ClearPoint Neuro's operating lease right-of-use assets in other assets?
Over 5 years (2020 to 2025), ClearPoint Neuro's operating lease right-of-use assets in other assets has grown at a 25.2% compound annual growth rate (CAGR), from $2.74M to $8.43M.